scholarly journals Fournier’s gangrene as a rare complication in patient with uncontrolled type 2 diabetes treated with surgical debridement: A case report and literature review

2021 ◽  
Vol 79 ◽  
pp. 462-465
Author(s):  
D. Provenzano ◽  
S. Lo Bianco ◽  
M. Zanghì ◽  
A. Campione ◽  
R. Vecchio ◽  
...  
Keyword(s):  
Type 2 Diabetes ◽  
Case Report ◽  
Literature Review ◽  
Rare Complication ◽  
Fournier’S Gangrene ◽  
Surgical Debridement ◽  
Fournier's Gangrene

scholarly journals Fournier’s Gangrene in a Patient with Type 2 Diabetes Mellitus Treated with Empagliflozin: A Case Report

2019 ◽  
Vol 6 (1) ◽  
Author(s):  
Yasunori Nagano ◽  
Naomi Kashiwagi Yakame ◽  
Hisae Aoki ◽  
Tamaki Yamakawa ◽  
Naoko Iwahashi Kondo
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Case Report ◽  
Fournier’S Gangrene ◽  
Fournier's Gangrene

A case of Fournier’s gangrene diagnosed with POCUS

POCUS Journal ◽  
2019 ◽  
Vol 4 (1) ◽  
pp. 3
Author(s):  
Marco Badinella Martini, MD ◽  
Antonello Iacobucci, MD
Keyword(s):  
Type 2 Diabetes ◽  
Emergency Department ◽  
Alzheimer Disease ◽  
Physical Examination ◽  
Subcutaneous Emphysema ◽  
Vital Signs ◽  
Fournier’S Gangrene ◽  
Fournier's Gangrene ◽  
History Of

An 87-year-old man with a history of type 2 diabetes and severe Alzheimer disease was admitted to the emergency department with a lesion of the perineum for two days. The patient appeared agitated and not collaborating on the visit. His vital signs were normal. Physical examination revealed an edematous, suppurative, and foul-smelling perineal-scrotal lesion, with possible subcutaneous emphysema.

Author response for "Fournier's gangrene in patients with type 2 diabetes using second‐line antidiabetic medications"

2019 ◽  
Author(s):  
Natalia Petruski‐Ivleva ◽  
Sebastian Schneeweiss ◽  
Sara Eapen ◽  
Aditya Rajan ◽  
Saira Jan
Keyword(s):  
Type 2 Diabetes ◽  
Fournier’S Gangrene ◽  
Author Response ◽  
Second Line ◽  
Fournier's Gangrene

scholarly journals Necrotising fasciitis in a patient treated with FOLFIRI-aflibercept for colorectal cancer: a case report

2017 ◽  
Vol 99 (8) ◽  
pp. e225-e226 ◽  
Author(s):  
A Gonzaga-López ◽  
J Muñoz-Rodriguez ◽  
A Ruiz-Casado
Keyword(s):  
Colorectal Cancer ◽  
Case Report ◽  
Folinic Acid ◽  
Rare Complication ◽  
Stage Iv ◽  
Fournier’S Gangrene ◽  
Necrotising Fasciitis ◽  
Fournier's Gangrene ◽  
Rectosigmoid Cancer

Anti-angiogenics have become an important part of the treatment of several types of tumours such as ovarian, breast, lung and colorectal cancer. Necrotising fasciitis has been reported with bevacizumab but no cases have been reported with aflibercept, ramucirumab or regorafenib in patients with colorectal cancer. Necrotising fasciitis is a rare complication affecting one in 5000 bevacizumab users. We report the case of a 64-year-old man with stage IV rectosigmoid cancer under treatment with folinic acid, fluorouracil and irinotecan (FOLFIRI) and aflibercept, who developed a Fournier’s gangrene.

Sign in / Sign up

Export Citation Format

Share Document